Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-009486
Filing Date
2023-03-23
Accepted
2023-03-23 16:09:49
Documents
85
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cyt-20221231.htm   iXBRL 10-K 2887142
2 EX-10.12 cyt-ex10_12.htm EX-10 138221
3 EX-23.1 cyt-ex23_1.htm EX-23 8122
4 EX-31.1 cyt-ex31_1.htm EX-31 20753
5 EX-31.2 cyt-ex31_2.htm EX-31 20729
6 EX-32.1 cyt-ex32_1.htm EX-32 12002
7 EX-32.2 cyt-ex32_2.htm EX-32 11988
8 GRAPHIC img141165676_0.jpg GRAPHIC 175027
9 GRAPHIC img141165676_1.jpg GRAPHIC 183597
  Complete submission text file 0000950170-23-009486.txt   10267284

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cyt-20221231_pre.xml EX-101.PRE 353351
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cyt-20221231_cal.xml EX-101.CAL 48353
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cyt-20221231_lab.xml EX-101.LAB 471436
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cyt-20221231_def.xml EX-101.DEF 189221
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cyt-20221231.xsd EX-101.SCH 54331
79 EXTRACTED XBRL INSTANCE DOCUMENT cyt-20221231_htm.xml XML 1585548
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40499 | Film No.: 23756288
SIC: 2834 Pharmaceutical Preparations